{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:03:10Z","timestamp":1791936190527,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":2348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1093\/bja\/aer132","type":"journal-article","created":{"date-parts":[[2011,5,30]],"date-time":"2011-05-30T20:59:40Z","timestamp":1306789180000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":198,"title":["Malignant hyperthermia: pharmacology of triggering"],"prefix":"10.1016","volume":"107","author":[{"given":"P.M.","family":"Hopkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1093\/bja\/aer132_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0310057X0703501s05","article-title":"Unravelling the mystery of malignant hyperthermia","volume":"3","author":"Ball","year":"2007","journal-title":"Anaesth Intensive Care"},{"key":"10.1093\/bja\/aer132_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/bja\/34.6.395","article-title":"Anaesthetic deaths in a family","volume":"34","author":"Denborough","year":"1962","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archopht.1975.01010020240014","article-title":"Idiopathic malignant hyperthermia. Review and report of a case","volume":"93","author":"Bergman","year":"1975","journal-title":"Arch Ophthalmol"},{"key":"10.1093\/bja\/aer132_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00000542-198202000-00010","article-title":"Malignant hyperthermia triggered by cyclopropane during cesarean section","volume":"5","author":"Lips","year":"1982","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/bmj.2.5806.145","article-title":"Further studies of porcine malignant hyperthermia","volume":"2","author":"Hall","year":"1972","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aer132_bib6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2460\/ajvr.1981.42.04.604","article-title":"Malignant hyperthermia-triggering liability of selected inhalant anesthetics in swine","volume":"42","author":"McGrath","year":"1981","journal-title":"Am J Vet Res"},{"key":"10.1093\/bja\/aer132_bib7","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archsurg.1975.01360180061013","article-title":"Malignant hyperthermia associated with enflurane anesthesia","volume":"110","author":"Caropreso","year":"1975","journal-title":"Arch Surg"},{"key":"10.1093\/bja\/aer132_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1213\/00000539-197501000-00009","article-title":"Malignant hyperthermia associated with enflurane anesthesia: a case report","volume":"54","author":"Pan","year":"1975","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1213\/00000539-198208000-00019","article-title":"Malignant hyperthermia associated with isoflurane anesthesia","volume":"61","author":"Joseph","year":"1982","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1399-6576.1986.tb02416.x","article-title":"A fatal case of malignant hyperthermia following isoflurane anaesthesia","volume":"30","author":"Jensen","year":"1986","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1093\/bja\/aer132_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000542-199110000-00024","article-title":"Malignant hyperthermia during sevoflurane anesthesia in a child with central core disease","volume":"75","author":"Otsuka","year":"1991","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1213\/00000539-199204000-00027","article-title":"Possible association of malignant hyperthermia with sevoflurane anesthesia","volume":"74","author":"Ochiai","year":"1992","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/BF03017952","article-title":"Malignant hyperthermia involving the administration of desflurane","volume":"43","author":"Fu","year":"1996","journal-title":"Can J Anaesth"},{"key":"10.1093\/bja\/aer132_bib14","first-page":"461","article-title":"A case of suspected malignant hyperthermia during desflurane administration","volume":"85","author":"Michalek-Sauberer","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000542-197804000-00006","article-title":"An in-vitro model of malignant hyperthermia: differential effects of inhalation anesthetics on caffeine-induced muscle contractures","volume":"48","author":"Reed","year":"1978","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03006841","article-title":"Comparison of effects of several inhalation anaesthetics on caffeine-induced contractures of normal and malignant hyperthermic skeletal muscle","volume":"27","author":"Britt","year":"1980","journal-title":"Can Anaesth Soc J"},{"key":"10.1093\/bja\/aer132_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/bja\/69.5.468","article-title":"Is the \u2018K-type\u2019 caffeine-halothane responder susceptible to malignant hyperthermia?","volume":"69","author":"Ellis","year":"1992","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/bja\/aep204","article-title":"Genetic variation in RYR1 and malignant hyperthermia phenotypes","volume":"103","author":"Carpenter","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1213\/00000539-200301000-00034","article-title":"Delayed onset of malignant hyperthermia in desflurane anesthesia","volume":"96","author":"Hoenemann","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","article-title":"A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility","volume":"56","author":"The European Malignant Hyperpyrexia Group","year":"1984","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/bja\/88.6.870","article-title":"No response to trigger agents in a malignant hyperthermia-susceptible patient","volume":"88","author":"Claxton","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006","volume":"110","author":"Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF03010752","article-title":"The anaesthetic management of the malignant hyperthermia susceptible parturient","volume":"33","author":"Douglas","year":"1986","journal-title":"Can Anaesth Soc J"},{"key":"10.1093\/bja\/aer132_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0310057X0303100112","article-title":"Preparing a new generation anaesthetic machine for patients susceptible to malignant hyperthermia","volume":"31","author":"Schonell","year":"2003","journal-title":"Anaesth Intensive Care"},{"key":"10.1093\/bja\/aer132_bib25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/00000542-200204000-00023","article-title":"Preparation of the Siemens KION anesthetic machine for patients susceptible to malignant hyperthermia","volume":"96","author":"Petroz","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2044.1997.070-az0061.x","article-title":"Occupational exposure to sevoflurane, halothane and nitrous oxide during paediatric anaesthesia. Waste gas exposure during paediatric anaesthesia","volume":"52","author":"Hoerauf","year":"1997","journal-title":"Anaesthesia"},{"key":"10.1093\/bja\/aer132_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/ALN.0b013e3181ee2cb7","article-title":"Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice","volume":"114","author":"Kim","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/bja\/aeq243","article-title":"Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group","volume":"105","author":"Glahn","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-2044.1993.tb07414.x","article-title":"Effects of three different types of management on the elimination kinetics of volatile anaesthetics. Implications for malignant hyperthermia treatment","volume":"48","author":"Reber","year":"1993","journal-title":"Anaesthesia"},{"key":"10.1093\/bja\/aer132_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF03004694","article-title":"Malignant hyperthermia: a statistical review","volume":"17","author":"Britt","year":"1970","journal-title":"Can Anaesth Soc J"},{"key":"10.1093\/bja\/aer132_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/bmj.3.5826.559","article-title":"Screening for malignant hyperpyrexia","volume":"3","author":"Ellis","year":"1972","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aer132_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/bmj.3.5772.454","article-title":"Anaesthetic-induced malignant hyperpyrexia: a suggested method of treatment","volume":"3","author":"Harrison","year":"1971","journal-title":"Br Med J"},{"key":"10.1093\/bja\/aer132_bib33","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1213\/00000539-197311000-00010","article-title":"Porcine malignant hyperthermia: a study on the triggering effects of succinylcholine","volume":"52","author":"Nelson","year":"1973","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1213\/00000539-199407000-00027","article-title":"Response to succinylcholine in porcine malignant hyperthermia","volume":"79","author":"Iaizzo","year":"1994","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib35","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/00000542-200006000-00038","article-title":"Malignant hyperthermia phenotype: hypotension induced by succinylcholine in susceptible swine","volume":"92","author":"Sigg","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/bja\/62.5.540","article-title":"Is there a relationship between masseteric muscle spasm and malignant hyperpyrexia?","volume":"62","author":"Christian","year":"1989","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib37","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2044.1990.tb14566.x","article-title":"Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probands","volume":"45","author":"Ellis","year":"1990","journal-title":"Anaesthesia"},{"key":"10.1093\/bja\/aer132_bib38","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1365-2044.1996.tb14965.x","article-title":"Serum and urinary myoglobin following an aborted malignant hyperthermia reaction","volume":"51","author":"Laurence","year":"1996","journal-title":"Anaesthesia"},{"key":"10.1093\/bja\/aer132_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1213\/00000539-199308000-00014","article-title":"Malignant hyperthermia: a review of published cases","volume":"77","author":"Strazis","year":"1993","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib40","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib41","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00000542-199406000-00009","article-title":"Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis","volume":"80","author":"O\u2019Flynn","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/bja\/aeq036","article-title":"Anaesthesia and the sex-linked dystrophies: between a rock and a hard place","volume":"104","author":"Hopkins","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/bja\/75.6.675","article-title":"Use of suxamethonium in children","volume":"75","author":"Hopkins","year":"1995","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.ejhg.5200964","article-title":"Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?","volume":"11","author":"Robinson","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1093\/bja\/aer132_bib45","first-page":"1039","article-title":"Creatine kinase alterations after acute malignant hyperthermia episodes and common surgical procedures","volume":"81","author":"Antognini","year":"1995","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0310057X0203000410","article-title":"Suspected malignant hyperthermia reactions in New Zealand","volume":"30","author":"Pollock","year":"2002","journal-title":"Anaesth Intensive Care"},{"key":"10.1093\/bja\/aer132_bib47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/bja\/85.1.118","article-title":"Malignant hyperthermia: advances in clinical management and diagnosis.","volume":"85","author":"Hopkins","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/bja\/aeg172","article-title":"Effects of a 5HT(2) receptor agonist on anaesthetized pigs susceptible to malignant hyperthermia","volume":"91","author":"Gerbershagen","year":"2003","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib49","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/00000542-200304000-00022","article-title":"In vitro and in vivo effects of the phosphodiesterase-III inhibitor enoximone on malignant hyperthermia-susceptible swine","volume":"98","author":"Fiege","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0265021505000475","article-title":"Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine","volume":"22","author":"Fiege","year":"2005","journal-title":"Eur J Anaesthesiol"},{"key":"10.1093\/bja\/aer132_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000542-200102000-00029","article-title":"Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermia","volume":"94","author":"Riess","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00003643-200407000-00013","article-title":"Malignant hyperthermia susceptibility revealed by increased serum creatine kinase concentrations during statin treatment","volume":"21","author":"Krivosic-Horber","year":"2004","journal-title":"Eur J Anaesthesiol"},{"key":"10.1093\/bja\/aer132_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/art.11013","article-title":"Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility","volume":"49","author":"Guis","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1093\/bja\/aer132_bib54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.22100","article-title":"In vivo and in vitro characterization of skeletal muscle metabolism in patients with statin-induced adverse effects","volume":"55","author":"Guis","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1093\/bja\/aer132_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/bja\/70.4.397","article-title":"Comparison of in vitro contracture testing with halothane, caffeine and ryanodine in patients with malignant hyperthermia and other neuromuscular disorders","volume":"70","author":"Hopkins","year":"1993","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2044.2007.04969.x","article-title":"Possible malignant hyperthermia during spinal anaesthesia with tetracaine","volume":"62","author":"Sheu","year":"2007","journal-title":"Anaesthesia"},{"key":"10.1093\/bja\/aer132_bib57","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00040.2008","article-title":"Calcium-induced calcium release in skeletal muscle","volume":"89","author":"Endo","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1093\/bja\/aer132_bib58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0005-2736(87)90422-6","article-title":"Effects of halothane, caffeine, dantrolene and tetracaine on the calcium permeability of skeletal sarcoplasmic reticulum of malignant hyperthermic pigs","volume":"897","author":"Ohnishi","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"10.1093\/bja\/aer132_bib59","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2044.2006.04619.x","article-title":"Hyperpyrexia and prolonged postoperative disorientation following methylene blue infusion during parathyroidectomy","volume":"61","author":"Mathew","year":"2006","journal-title":"Anaesthesia"},{"key":"10.1093\/bja\/aer132_bib60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0269881109359098","article-title":"CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity","volume":"25","author":"Gilman","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1093\/bja\/aer132_bib61","doi-asserted-by":"crossref","first-page":"e1514","DOI":"10.1542\/peds.2009-2795","article-title":"Administration of ondansetron is associated with lethal outcome","volume":"125","author":"Gener","year":"2010","journal-title":"Pediatrics"},{"key":"10.1093\/bja\/aer132_bib62","first-page":"A648","article-title":"A novel ryanodine receptor (RYR1) variant in two children with fatal spontaneous MH like events","volume":"109","author":"Muldoon","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib63","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1213\/00000539-198107000-00006","article-title":"Variations in onset of porcine malignant hyperthermia","volume":"60","author":"Gronert","year":"1981","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib64","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1213\/00000539-198504000-00009","article-title":"Malignant hyperthermia: is etomidate safe?","volume":"64","author":"Suresh","year":"1985","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib65","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1213\/00000539-198906000-00010","article-title":"The screening of propofol in MHS swine","volume":"68","author":"Raff","year":"1989","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF03006069","article-title":"Malignant hyperthermia induced by curare","volume":"24","author":"Britt","year":"1974","journal-title":"Can Anaesth Soc J"},{"key":"10.1093\/bja\/aer132_bib67","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/bja\/48.12.1135","article-title":"Porcine malignant hyperthemia IV: neuromuscular blockade","volume":"48","author":"Hall","year":"1976","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1213\/00000539-198505000-00012","article-title":"Vecuronium and porcine malignant hyperthermia","volume":"64","author":"Buzello","year":"1985","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/aer132_bib69","first-page":"709P","article-title":"Use of non-depolarizing neuromuscular blocking drugs and markers of severity of malignant hyperthermia reactions","volume":"105","author":"Young","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib70","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in ryr1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1093\/bja\/aer132_bib71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF03007458","article-title":"In vivo and in vitro responses to magnesium sulphate in porcine malignant hyperthermia","volume":"27","author":"Flewellen","year":"1980","journal-title":"Can Anaesth Soc J"},{"key":"10.1093\/bja\/aer132_bib72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1113\/jphysiol.2002.022749","article-title":"Effects of Mg2+ and SR luminal Ca2+ on caffeine-induced Ca2+ release in skeletal muscle from humans susceptible to malignant hyperthermia","volume":"544","author":"Duke","year":"2002","journal-title":"J Physiol"},{"key":"10.1093\/bja\/aer132_bib73","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/S0006-3495(97)78222-5","article-title":"Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia","volume":"73","author":"Laver","year":"1997","journal-title":"Biophys J"},{"key":"10.1093\/bja\/aer132_bib74","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/00000542-200412000-00014","article-title":"Mg2+-dependence of halothane-induced Ca2+ release from the sarcoplasmic reticulum in skeletal muscle from humans susceptible to malignant hyperthermia","volume":"101","author":"Duke","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/aer132_bib75","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/bja\/ael179","article-title":"Mg2+-dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia","volume":"97","author":"Duke","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aer132_bib76","doi-asserted-by":"crossref","first-page":"25645","DOI":"10.1074\/jbc.M110.104976","article-title":"Store operated Ca2+ entry in malignant hyperthermia-susceptible human skeletal muscle","volume":"285","author":"Duke","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1093\/bja\/aer132_bib77","doi-asserted-by":"crossref","first-page":"37471","DOI":"10.1074\/jbc.M701379200","article-title":"Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1093\/bja\/aer132_bib78","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1085\/jgp.200910328","article-title":"A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR","volume":"135","author":"Est\u00e8ve","year":"2010","journal-title":"J Gen Physiol"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217331513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217331513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/107\/1\/48\/945152\/aer132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:43:18Z","timestamp":1757788998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217331513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0007091217331513"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aer132","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant hyperthermia: pharmacology of triggering","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/bja\/aer132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Author(s). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}